QIAGEN N.V.: QIAGEN receives U.S. FDA emergency use authoriz

QIAGEN N.V.: QIAGEN receives U.S. FDA emergency use authorization for rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen